A comparison of masking effects of haloperidol versus molindone in tardive dyskinesia

Schizophrenia Research

Volumn 3, Issue 5-6, 1990, Pages 315-320

  Glazer, William M ^a,b   Hafez, Hisham ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Brookside Hospital   (United States)

Author keywords

Haloperidol; Molindone; Neuroleptic; Tardive dyskinesia

Indexed keywords

HALOPERIDOL; MOLINDONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HUMAN; MASKING; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; TARDIVE DYSKINESIA;

ADULT; ANTIPSYCHOTIC AGENTS; DYSKINESIA, DRUG-INDUCED; FEMALE; HALOPERIDOL; HUMANS; MALE; MOLINDONE; NEUROLOGIC EXAMINATION; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SINGLE-BLIND METHOD; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 0025188157     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/0920-9964(90)90016-Z     Document Type: Article

References (24)

1. Physiological significance of dopamine autoreceptors as studied following their selective blockade by molindone
2. Antipsychotic agents
3. Atypical and typical neuroleptics and tardive dyskinesia
4. Effects of molindone on central dopaminergic neuronal activity and metabolism: Similarity to other neuroleptics
5. A diagnostic interview: The schedule for affective disorders and schizophrenia
6. Molindone: higher doses needed to block pergolide-induced elevation of serum corticosterone than to elevate dopamine metabolites in brain
7. Tardive dyskinesia during and following treatment with haloperidol, haloperidol+biperiden, thorazine and clozapine
8. Noradrenergic function and tardive dyskinesia
9. A tardive dyskinesia clinic in a mental health center
10. Molindone and haloperidol in tardive dyskinesia
11. Presynaptic nd postsynaptic roles of cyclic AMP and protein phosphorylation at catecholaminergic synapses
12. the pharmacology of tardive dyskinesia
13. Molindone compared to haloperidol in a guinea-pig model of tardive dyskinesia
14. Selective effects of buspirone and molindone on dopamine metabolism and function in the striatum and frontal cortex of the rat
15. Chronic molindone treatment: Relative inability to elicit dopamine receptor supersensitivity in rats
16. Effect of different neuroleptics in tardive dyskinesia and parkinsonism
17. The brief psychiatric rating scale
18. Molindone hydrochloride: A review of laboratory and clinical findings
19. Pharmacology of neuroleptics in the United States
20. Treatment outcome with clozapine in tardive dyskinesia, neuroleptic sensitivity, and treatment-resistant psychosis
21. A systematic investigation of tardive dyskinesia in inpatients
22. Critical analysis of the disability in Parkinson's disease
23. Differential effects of classical and atypical antipsychotic drugs on A9 and A10 dopamine neurons